Search for: "Aventis Pharmaceuticals, Inc."
Results 41 - 60
of 219
Sort by Relevance
|
Sort by Date
14 May 2015, 4:00 am
In Eli Lilly Canada Inc. v. [read post]
5 Feb 2015, 1:44 pm
Aventis Pasteur, Inc., 270 F. [read post]
18 Jan 2015, 9:06 pm
LLC; Aventis Pharma S.A.; Sanofi • Defendant: Breckenridge Pharmaceutical, Inc. [read post]
21 Nov 2014, 4:00 am
Over the past few years the pharmaceutical marketplace has seen an increase in patent “re-litigation” (where a patentee is involved in a second case against another generic). [read post]
16 Nov 2014, 4:00 am
Pharmaceuticals: Delayed Market EntryApotex Inc. v. [read post]
18 Jul 2014, 11:55 am
Wyeth Pharmaceuticals, Inc., 2008 WL 7136137 (Ala. [read post]
7 Jul 2014, 11:34 am
Originally, Amphastar Pharmaceuticals, Inc. and Sanofi-Aventis S.A. battled it out in 2008 in a patent dispute over Sanofi-Aventis’s anticoagulant drug. [read post]
15 Jun 2014, 8:46 pm
.; Glenmark Generics Inc., USA • Defendant: Ferring, B.V. [read post]
30 Apr 2014, 10:00 pm
Glenmark Pharmaceuticals Inc., USA, addresses several interesting issues, but is most likely to be cited by other patent holders for its affirmance of the jury verdict that upheld the Tarka patent at issue. [read post]
24 Apr 2014, 9:59 pm
By Michael Greenfield -- On April 21, 2014, a Federal Circuit panel reiterated its interpretation and application to the chemical arts of the KSR obviousness standard. [read post]
22 Apr 2014, 7:41 am
In 2007 the defendants Glenmark Pharmaceuticals Inc. and Glenmark Pharmaceuticals Ltd. [read post]
19 Apr 2014, 8:50 am
Sanofi-Aventis, Annual Report (Form 20-F), at 61 (Mar. 7, 2008); Teva Pharmaceutical Industries Ltd., Annual Report (Form 20-F), at 20 (Mar. 31, 2001). [read post]
14 Mar 2014, 1:02 pm
The individual filed suit in Cook County Circuit Court against Bristol-Myers Squibb Co., Sanofi-Aventis US LLC, Sanofi-Aventis US Inc., and Sanofi-Synthelabo Inc. in a claim of strict product liability, manufacturing defect, negligence, and failure to warn. [read post]
16 Feb 2014, 4:00 am
” LEAVES TO APPEAL GRANTED Pharmaceuticals: Utility; Obviousness Is the patent valid here.Apotex Inc., et al. v. [read post]
17 Oct 2013, 5:00 am
Mutual Pharmaceutical Co., 731 F. [read post]
3 Jun 2013, 9:59 pm
Inc. v. [read post]
27 May 2013, 7:22 pm
See Pharmaceuticals v. [read post]
20 May 2013, 11:52 pm
” See Aventis Pharms., Inc. v. [read post]
4 Jan 2013, 7:03 am
Momenta Pharmaceuticals, Inc. v. [read post]
3 Jan 2013, 4:00 am
Justice Snider has written in Sanofi-Aventis Canada Inc v Novopharm Ltd, 2009 FC 1139: A review of recent jurisprudence on the issue of awards in intellectual property trials indicates that this scale recognizes the significance and complexity of the various issues in such a trial. [read post]
